Stock listing

OTC:MLNT Melinta Therapeutics Inc Stock

Follow Melinta Therapeutics Inc into a list and get an email when it puts out news.

Delisted OTC:MLNT no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
OTC:MLNT
Asset type
Stock
Exchange
OTC
Currency
USD

Where Melinta Therapeutics Inc is listed

ListingExchangeCountryCurrency
OTC:MLNT · This page · DelistedOTCUnited StatesUSD
OTC:MLNTQ · DelistedOTCUnited StatesUSD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
John H. Johnson
Other companies: Xeris Biopharma Holdings, Inc. (Independent, Non-executive Board Member · Since at least Oct 5, 2021); Axogen, Inc. (Director · Since at least Jul 19, 2021); Verastem, Inc. (Director · Since at least Apr 23, 2020); Applied Therapeutics Inc (Executive Chairman, Director · Dec 19, 2024 – Dec 19, 2024 · Past); AVEO Pharmaceuticals Inc (Director · Feb 1, 2018 – Feb 1, 2018 · Past); Strongbridge Biopharma plc (Chief Executive Officer, Director · Jan 1, 2018 – Oct 5, 2021 · Past); Cempra Inc (Director · Jan 3, 2017 – Jan 3, 2017 · Past); Ocugen, Inc. (Director · Dec 16, 2016 – Jun 15, 2018 · Past); Portola Pharmaceuticals Inc (Director · Jun 17, 2016 – Jul 2, 2020 · Past); Sucampo Pharmaceuticals Inc (Director · Jun 2, 2016 – Feb 13, 2018 · Past)
Chief Executive Officer, Director · Jun 12, 2018 – Jun 27, 2019 · Past
David Gill
Other companies: Telix Pharmaceuticals Limited (Chair & Independent Non-Executive Director · Since at least May 11, 2026); Y mAbs Therapeutics (Director · Since at least Sep 20, 2018); Evolus, Inc. Common Stock (Director · Since at least Feb 12, 2018); Strongbridge Biopharma plc (Director · Sep 3, 2019 – Oct 5, 2021 · Past); STRATA Skin Sciences, Inc. (Director · May 30, 2018 – Nov 22, 2019 · Past); Ocugen, Inc. (Director · Dec 9, 2016 – Jun 15, 2018 · Past); Cempra Inc (Director · Jan 1, 2016 – Jan 3, 2017 · Past); EndoChoice Holdings Inc (President and CFO · Aug 14, 2015 – Nov 22, 2016 · Past)
Director · May 25, 2018 – Jun 11, 2019 · Past
Susan Blum
Other companies: CorMedix Inc. (EVP & Chief Financial Officer · Since at least Aug 29, 2025); BiomX Inc. (Director · Apr 11, 2024 – Apr 14, 2025 · Past)
VP of Finance & CAO · Oct 17, 2019 – Oct 17, 2019 · Past
Thomas P Koestler
Other companies: Momenta Pharmaceuticals Inc (Director · Jun 23, 2016 – Jun 19, 2019 · Past)
Director · Nov 3, 2017 – Jun 11, 2019 · Past
Daniel Mark WechslerSee Remarks, Director · Nov 3, 2017 – Jun 12, 2018 · Past
Jennifer A Sanfilippointerim Chief Executive Office, Director · Sep 5, 2019 – Sep 5, 2019 · Past
John TemperatoChief Commercial Officer · Nov 3, 2017 – Nov 3, 2017 · Past
Paul EstremChief Financial Officer · Nov 3, 2017 – Jun 12, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about Melinta Therapeutics Inc.